Flow chart illustrating the sample inclusion/exclusion process (NM cores). A total of 301 PC patients were represented by NM cores on the TMA. The final sample set used for all subsequent analyses consisted of 5hmC scores from 228 PC patients for whom at least 2 NM cores could be evaluated for 5hmC staining intensity (grade). (TIFF 58 kb
Table S1D. Clinical characteristics for PC patients represented on the TMA. Data for RP patients for...
Figure S5. Correlations between 5fC score and clinicopathological parameters. A) In the full PC set ...
Figure S3. Correlations between 5mC score and clinicopathological parameters. A) In the full PC set ...
Flow chart illustrating the sample inclusion/exclusion process (malignant cores). A total of 552 PC ...
Kaplan-Meier analysis: 5hmC score and time to BCR in ERG− PC stratified by pT stage. A: High 5hmC sc...
Distribution of 5hmC scores by clinicopathological parameters and BCR in the full PC patient set. Fu...
Distribution of 5hmC scores by clinicopathological parameters and BCR status in ERG− PC. ERG− subset...
Distribution of 5hmC scores by clinicopathological parameters and BCR status in ERG+ PC. ERG+ subset...
Uni- and multivariate Cox regression analysis of BCR after RP in the full PC patient set. 5hmC analy...
Uni- and multivariate Cox regression analysis of BCR after RP in ERG−/ERG+ PC patients. 5hmC analyze...
Figure S2. Flow chart illustrating the sample inclusion/exclusion process in NM cores. A) 5mC score....
Figure S1. Flow chart illustrating the sample inclusion/exclusion process in malignant cores. A) 5mC...
Table S1B. Clinical characteristics for PC patients represented on the TMA. Data for RP patients for...
Figure S6. Correlations between 5caC score and clinicopathological parameters. A) In the full PC set...
Figure S4. Correlations between 5hmC score and clinicopathological parameters. A) In the full PC set...
Table S1D. Clinical characteristics for PC patients represented on the TMA. Data for RP patients for...
Figure S5. Correlations between 5fC score and clinicopathological parameters. A) In the full PC set ...
Figure S3. Correlations between 5mC score and clinicopathological parameters. A) In the full PC set ...
Flow chart illustrating the sample inclusion/exclusion process (malignant cores). A total of 552 PC ...
Kaplan-Meier analysis: 5hmC score and time to BCR in ERG− PC stratified by pT stage. A: High 5hmC sc...
Distribution of 5hmC scores by clinicopathological parameters and BCR in the full PC patient set. Fu...
Distribution of 5hmC scores by clinicopathological parameters and BCR status in ERG− PC. ERG− subset...
Distribution of 5hmC scores by clinicopathological parameters and BCR status in ERG+ PC. ERG+ subset...
Uni- and multivariate Cox regression analysis of BCR after RP in the full PC patient set. 5hmC analy...
Uni- and multivariate Cox regression analysis of BCR after RP in ERG−/ERG+ PC patients. 5hmC analyze...
Figure S2. Flow chart illustrating the sample inclusion/exclusion process in NM cores. A) 5mC score....
Figure S1. Flow chart illustrating the sample inclusion/exclusion process in malignant cores. A) 5mC...
Table S1B. Clinical characteristics for PC patients represented on the TMA. Data for RP patients for...
Figure S6. Correlations between 5caC score and clinicopathological parameters. A) In the full PC set...
Figure S4. Correlations between 5hmC score and clinicopathological parameters. A) In the full PC set...
Table S1D. Clinical characteristics for PC patients represented on the TMA. Data for RP patients for...
Figure S5. Correlations between 5fC score and clinicopathological parameters. A) In the full PC set ...
Figure S3. Correlations between 5mC score and clinicopathological parameters. A) In the full PC set ...